Tokyo District Court Dismisses Ajinomoto's Patent Infringement Case against Chugai Pharmaceutical.
Ajinomoto alleged that Chugai Pharmaceutical had infringed upon its patent in the process of manufacturing Epogin and Neutrogin, two ethical drugs marketed by Chugai Pharmaceutical.
Accordingly, Ajinomoto sought 3 billion yen ($25.4 mil) and statutory interest as compensation for the damage. The Japanese Patent Office (JPO) had already declared the relevant patent invalid as of September 2005.
Currently, the revocation suit against the JPO decision is pending at the Intellectual Property High Court.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Mar 27, 2006|
|Previous Article:||Lawson to Recycle Cooking Oil at All Stores.|
|Next Article:||RIKEN Research Center for Allergy and Immunology Discovers Mechanism for Regulating Immune Response.|